168 related articles for article (PubMed ID: 36436091)
1. COVID-19 related decline in cancer screenings most pronounced for elderly patients and women in Germany: a claims data analysis.
Muschol J; Strauss C; Gissel C
J Cancer Res Clin Oncol; 2023 Jul; 149(8):5345-5367. PubMed ID: 36436091
[TBL] [Abstract][Full Text] [Related]
2. Model-Based Estimation of Colorectal Cancer Screening and Outcomes During the COVID-19 Pandemic.
Issaka RB; Taylor P; Baxi A; Inadomi JM; Ramsey SD; Roth J
JAMA Netw Open; 2021 Apr; 4(4):e216454. PubMed ID: 33843997
[TBL] [Abstract][Full Text] [Related]
3. Modeling Strategies to Optimize Cancer Screening in USPSTF Guideline-Noncompliant Women.
Taksler GB; Peterse EFP; Willems I; Ten Haaf K; Jansen EEL; de Kok IMCM; van Ravesteyn NT; de Koning HJ; Lansdorp-Vogelaar I
JAMA Oncol; 2021 Jun; 7(6):885-894. PubMed ID: 33914025
[TBL] [Abstract][Full Text] [Related]
4. Impact of the COVID-19 Pandemic on Fecal Immunochemical Testing, Colonoscopy Services, and Colorectal Neoplasia Detection in a Large United States Community-based Population.
Lee JK; Lam AY; Jensen CD; Marks AR; Badalov J; Layefsky E; Kao K; Ho NJ; Schottinger JE; Ghai NR; Carlson CM; Halm EA; Green B; Li D; Corley DA; Levin TR
Gastroenterology; 2022 Sep; 163(3):723-731.e6. PubMed ID: 35580655
[TBL] [Abstract][Full Text] [Related]
5. COVID-19 and inequities in colorectal and cervical cancer screening and diagnosis in Washington State.
Amram O; Amiri S; Robison J; Pflugeisen CM; Monsivais P
Cancer Med; 2022 Aug; 11(15):2990-2998. PubMed ID: 35304835
[TBL] [Abstract][Full Text] [Related]
6. [Participation indicators of colorectal screenings in Hungary between 2008-2021].
Kívés Z; Bódis J; Hunyady B; Pónusz-Kovács D; Elmer D; Kajos FL; Csákvári T; Vajda R; Boncz I
Magy Onkol; 2022 Oct; 66(3):209-217. PubMed ID: 36200501
[TBL] [Abstract][Full Text] [Related]
7. Does mammogram attendance influence participation in cervical and colorectal cancer screening? A prospective study among 1856 French women.
Bertaut A; Coudert J; Bengrine L; Dancourt V; Binquet C; Douvier S
PLoS One; 2018; 13(6):e0198939. PubMed ID: 29927995
[TBL] [Abstract][Full Text] [Related]
8. Understanding COVID-19 impact on cervical, breast, and colorectal cancer screening among federally qualified healthcare centers participating in "Back on track with screening" quality improvement projects.
Fisher-Borne M; Isher-Witt J; Comstock S; Perkins RB
Prev Med; 2021 Oct; 151():106681. PubMed ID: 34217422
[TBL] [Abstract][Full Text] [Related]
9. An RCT to Increase Breast and Colorectal Cancer Screening.
Champion VL; Christy SM; Rakowski W; Lairson DR; Monahan PO; Gathirua-Mwangi WG; Stump TE; Biederman EB; Kettler CD; Rawl SM
Am J Prev Med; 2020 Aug; 59(2):e69-e78. PubMed ID: 32690203
[TBL] [Abstract][Full Text] [Related]
10. Impact of the COVID-19 Pandemic on Cancer Screening Delays.
Zhang X; Elsaid MI; DeGraffinreid C; Champion VL; Paskett ED;
J Clin Oncol; 2023 Jun; 41(17):3194-3202. PubMed ID: 36735899
[TBL] [Abstract][Full Text] [Related]
11. Regional variations in the use of statutory skin cancer screenings in Germany: population-based spatial multisource analysis.
Augustin J; Sorbe C; Augustin M; Zander N; Kis A
J Eur Acad Dermatol Venereol; 2020 Aug; 34(8):1736-1743. PubMed ID: 31981431
[TBL] [Abstract][Full Text] [Related]
12. Japanese cancer screening programs during the COVID-19 pandemic: Changes in participation between 2017-2020.
Machii R; Takahashi H
Cancer Epidemiol; 2023 Feb; 82():102313. PubMed ID: 36508964
[TBL] [Abstract][Full Text] [Related]
13. Impact of the COVID-19 pandemic on cancer screenings in Portugal.
Mendes D; Figueiredo D; Alves C; Penedones A; Costa B; Batel-Marques F
Cancer Epidemiol; 2024 Feb; 88():102496. PubMed ID: 38061274
[TBL] [Abstract][Full Text] [Related]
14. Utilization of Women's Preventive Health Services During the COVID-19 Pandemic.
Becker NV; Moniz MH; Tipirneni R; Dalton VK; Ayanian JZ
JAMA Health Forum; 2021 Jul; 2(7):e211408. PubMed ID: 35977205
[TBL] [Abstract][Full Text] [Related]
15. Impact of the COVID-19 Pandemic on Colorectal Cancer Screening: a Systematic Review.
Mazidimoradi A; Tiznobaik A; Salehiniya H
J Gastrointest Cancer; 2022 Sep; 53(3):730-744. PubMed ID: 34406626
[TBL] [Abstract][Full Text] [Related]
16. Rates of Follow-up Colonoscopy After a Positive Stool-Based Screening Test Result for Colorectal Cancer Among Health Care Organizations in the US, 2017-2020.
Mohl JT; Ciemins EL; Miller-Wilson LA; Gillen A; Luo R; Colangelo F
JAMA Netw Open; 2023 Jan; 6(1):e2251384. PubMed ID: 36652246
[TBL] [Abstract][Full Text] [Related]
17. The impact of COVID-19 on national program of colorectal cancer screening in Tehran, Iran: a multicenter study.
Sadeghi A; Asadzadeh Aghdaei H; Khalafi MA; Nazemalhosseini-Mojarad E; Ketabi Moghadam P; Sohrabi MR
BMC Cancer; 2023 Jul; 23(1):627. PubMed ID: 37407931
[TBL] [Abstract][Full Text] [Related]
18. The effect of gender-specific invitation letters on utilization of colorectal cancer screening.
Zhan T; Hielscher T; Eckardt M; Giese T; Schäfer C; Riemann JF; Ebert MP; Belle S
Z Gastroenterol; 2019 Sep; 57(9):1051-1058. PubMed ID: 31525797
[TBL] [Abstract][Full Text] [Related]
19. Association of Cancer Screening Deficit in the United States With the COVID-19 Pandemic.
Chen RC; Haynes K; Du S; Barron J; Katz AJ
JAMA Oncol; 2021 Jun; 7(6):878-884. PubMed ID: 33914015
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of Medicare cost-sharing elimination for Cancer screening on utilization.
Xu WY; Wickizer TM; Jung JK
BMC Health Serv Res; 2019 Jun; 19(1):392. PubMed ID: 31208422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
